Curry Koening is a Rheumatology/Immunology physician affiliated with University of Utah. OpenAlex indexes 97 publications with 4,475 citations (h-index 37).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
17 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
53.2%Corticosteroid53.2%Prednisone100%Part D≥16 patientsCancer & immunology
46.8%Interleukin-6 Receptor Antagonist29.8%Actemra Actpen54%Actemra46%Part D<11 patientsFolate Analog Metabolic Inhibitor17%Methotrexate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2013–2016 per NIH RePORTER. The latest:
- The role of Burkholderia in giant cell arteritis
Va Salt Lake City Healthcare System
FY2016I01CX000576 - The role of Burkholderia in giant cell arteritis
Va Salt Lake City Healthcare System
FY2015I01CX000576 - The role of Burkholderia in giant cell arteritis
Va Salt Lake City Healthcare System
FY2014I01CX000576
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Colman, MD
University of Utah
James Fang
University of Utah
Wallace Akerley, MD
University of Utah
Randall Burt, MD
University of Utah
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”